IPOS trademark

NeoMab

RegisteredIPOSWord markClass 5

"NeoMab" is a word mark owned by GemPharmatech Co., Ltd., filed at the IPOS on January 5, 2024. It is registered and covers class 5 (Pharmaceuticals).

Official IPOS record
NeoMab trademark as filed
As filed with the IPOS
Status
Registered
Since January 5, 2024
Filed
January 5, 2024
Registered
May 18, 2024
Expires
January 5, 2034
Application no.
40202400457Q
Registration no.
40202400457Q
Office
IPOS
Intellectual Property Office of Singapore
Mark type
Word mark
1 class
Ownership

Who owns NeoMab

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

GemPharmatech Co., Ltd.

China

31 trademarks in the portfolioView company

Representative

Quality Oracle Pte. Ltd.

Quality Oracle Pte. Ltd.

Goods and services

What the mark covers

The products and services NeoMab is filed for, grouped by Nice class.

  • Medicines for human purposes; Pharmaceutical preparations; Vaccines; Drugs for medical purposes; Biological preparations for medical purposes; Biochemical medicines; Bacterial poisons; Biological tissue cultures for medical purposes; Immunostimulants; Preparations of microorganisms for medical or veterinary use

History

What has happened so far

Steps recorded by the IPOS, newest first.

  1. Registration procedure completed
  2. Application filed
FAQ

About NeoMab

Who owns the trademark "NeoMab"?

The IPOS trademark "NeoMab" (application 40202400457Q) is owned by GemPharmatech Co., Ltd.

What is the status of "NeoMab"?

Its status at the IPOS is: registered.

When was "NeoMab" registered?

It was registered on May 18, 2024 and is due to expire on January 5, 2034.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NeoMab and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019df653-f68b-749f-852a-07942259d730
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019df653-f68b-749f-852a-07942259d730",
  "object": "trademark",
  "mark_text": "NeoMab",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "SG",
  "application_number": "40202400457Q",
  "filing_date": "2024-01-05",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "GemPharmatech Co., Ltd.",
      "entity_id": "ent_019eb7dd-5b13-70cd-880d-9b7bc5be78fb"
    }
  ]
}